PORTLAND, Ore.--(BUSINESS WIRE)--At the 20 th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other ...
Bruker Corporation BRKR recently announced transformative sensitivity on the 4D-Proteomics timsTOF platform with the launch of the timsTOF Ultra mass spectrometer at the 71st ASMS meeting. The company ...
A. Preview of timsTOF Ultra 2 system with novel Athena Ion Processor (AIP): - Improves protein group identification in single-cell proteomics (SCP) by 15%-20%, and ...
timsTOF Ultra Further Advances Quantitative Spatial and Single-cell 4D-Proteomics and 4D-Lipidomics™, Immunopeptidomics, PTM and Protein-Protein Interactions Analysis - with Speed and Robustness ...
HELSINKI, Finland, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer, announces it is the first biotech company in Europe to ...
Ion-mobility spectrometry (IMS) separates and characterizes ions in the gas phase based on their mobility within a carrier gas. IMS has recently being coupled with mass spectrometry (MS) and ...
The timsTOF fleX integrates best-in-class 4D X-Omics with Bruker’s revolutionary MALDI Imaging technology, including SmartBeam 3D laser optics for rapid measurement all-in-one system, based on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback